catalog number :
MBS534692
products full name :
CYP2D6 antibody
products short name :
CYP2D6
products name syn :
Polyclonal CYP2D6; Anti-CYP2D6; Cytochrome P450 2D6; CYPD6 -2; CYPD6 2; CYP2D6
other names :
cytochrome P450 2D6 isoform 1; Cytochrome P450 2D6; cytochrome P450 2D6; cytochrome P450, family 2, subfamily D, polypeptide 6; CYPIID6; Cytochrome P450-DB1; Debrisoquine 4-hydroxylase
products gene name :
CYP2D6
other gene names :
CYP2D6; CYP2D6; CPD6; CYP2D; CYP2DL1; CYPIID6; P450C2D; P450DB1; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; P450-DB1; CYP2DL1
uniprot entry name :
CP2D6_HUMAN
reactivity :
To be determined by end-user
form :
Supplied as antiserum.
storage stability :
Aliquot and store at -20 degree C. Avoid repeated Freeze/Thaw cycles
tested application :
User optimized
other info1 :
Biological Significance: Cytochrome P450 2D6, a member of the cytochrome P450 mixed-function oxidase system, is one of the most important enzymes involved in the metabolism of xenobiotics in the body. Also, many substances are bioactivated by CYP2D6 to form their active compounds. While CYP2D6 is involved in the oxidation of a wide range of substrates of all the CYPs, there is considerable variability in its expression in the liver. The gene is located near two cytochrome P450 pseudogenes on chromosome 22q13.1.
other info2 :
Immunogen: CYP2D6 antibody was raised in rabbit using recombinant human P450 2D6 expressed in E Coli as the immunogen.
products categories :
Proteases, Inhibitors, & Enzymes
products description :
Rabbit polyclonal CYP2D6 antibody
ncbi gb acc num :
NM_000106.5
ncbi mol weight :
50,061 Da
ncbi pathways :
Biological Oxidations Pathway 105698!!CYP2E1 Reactions Pathway 105705!!Codeine And Morphine Metabolism Pathway 198831!!Cytochrome P450 - Arranged By Substrate Type Pathway 105700!!Drug Metabolism - Cytochrome P450 Pathway 83032!!Drug Metabolism - Cytochrome P450 Pathway 427!!Fatty Acid Omega Oxidation Pathway 198915!!Fatty Acids Pathway 105706!!Metabolism Pathway 477135!!Metabolism Of Xenobiotics By Cytochrome P450 Pathway 83031
ncbi summary :
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]